Subchronic duloxetine administration alters the extended amygdala circuitry in healthy individuals

NeuroImage

Volumn 55, Issue 2, 2011, Pages 825-831

  van Marle, Hein J F ^a,b   Tendolkar, Indira ^a,b   Urner, Maren ^a   Verkes, Robbert J ^a,b   Fernández, Guillén ^a,b   van Wingen, Guido ^a,b  

^a RADBOUD UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amygdala; Depression; Duloxetine; Emotion; FMRI; Insula

Indexed keywords

DULOXETINE; PLACEBO;

ADULT; AFFECT; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EMOTIONALITY; FACIAL EXPRESSION; FATIGUE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; INSOMNIA; INSULA; MALE; MORNING DOSAGE; NERVOUSNESS; NORMAL HUMAN; PRIORITY JOURNAL; SIDE EFFECT; TASK PERFORMANCE; THALAMUS; VOLUNTEER;

ADOLESCENT; ADULT; AMYGDALA; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EMOTIONS; FACIAL EXPRESSION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PHOTIC STIMULATION; THIOPHENES; YOUNG ADULT;

EID: 79551582443     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.12.051     Document Type: Article

References (50)

1. Anand A., Li Y., Wang Y., Gardner K., Lowe M.J. Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study. J. Neuropsychiatry Clin. Neurosci. 2007, 19:274-282.
2. Anand A., Li Y., Wang Y., Wu J., Gao S., Bukhari L., Mathews V.P., Kalnin A., Lowe M.J. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacology 2005, 30:1334-1344.
3. Anderson I.M., Del-Ben C.M., McKie S., Richardson P., Williams S.R., Elliott R., Deakin J.F. Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. NeuroReport 2007, 18:1351-1355.
4. Arce E., Simmons A.N., Lovero K.L., Stein M.B., Paulus M.P. Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 2008, 196:661-672.
5. Augustine J.R. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res. Brain Res. Rev. 1996, 22:229-244.
6. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
7. Bigos K.L., Pollock B.G., Aizenstein H.J., Fisher P.M., Bies R.R., Hariri A.R. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 2008, 33:3221-3225.
8. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. 2000, 4:215-222.
9. Chen C.H., Suckling J., Ooi C., Fu C.H., Williams S.C., Walsh N.D., Mitterschiffthaler M.T., Pich E.M., Bullmore E. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology 2008, 33:1909-1918.
10. Cools R., Roberts A.C., Robbins T.W. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn. Sci. 2008, 12:31-40.
11. Craig A.D. How do you feel? Interoception: the sense of the physiological condition of the body. Nat. Rev. Neurosci. 2002, 3:655-666.
12. Critchley H.D. Neural mechanisms of autonomic, affective, and cognitive integration. J. Comp. Neurol. 2005, 493:154-166.
13. Davis M., Whalen P.J. The amygdala: vigilance and emotion. Mol. Psychiatry 2001, 6:13-34.
14. Del-Ben C.M., Deakin J.F., McKie S., Delvai N.A., Williams S.R., Elliott R., Dolan M., Anderson I.M. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 2005, 30:1724-1734.
15. DeRubeis R.J., Siegle G.J., Hollon S.D. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat. Rev. Neurosci. 2008, 9:788-796.
16. Devinsky O., Morrell M.J., Vogt B.A. Contributions of anterior cingulate cortex to behaviour. Brain 1995, 118(Pt 1):279-306.
17. Drevets W.C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog. Brain Res. 2000, 126:413-431.
18. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry 2000, 48:813-829.
19. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann. NY Acad. Sci. 2003, 985:420-444.
20. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. J. Neurosci. 1992, 12:3628-3641.
21. Frampton J.E., Plosker G.L. Duloxetine: a review of its use in the treatment of major depressive disorder. CNS Drugs 2007, 21:581-609.
22. Friston K.J., Holmes A.P., Worsley K.J., Poline J.B., Frith C.D., Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 1995, 2:189-210.
23. Fu C.H., Williams S.C., Cleare A.J., Brammer M.J., Walsh N.D., Kim J., Andrew C.M., Pich E.M., Williams P.M., Reed L.J., Mitterschiffthaler M.T., Suckling J., Bullmore E.T. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry 2004, 61:877-889.
24. Hariri A.R., Mattay V.S., Tessitore A., Fera F., Smith W.G., Weinberger D.R. Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology 2002, 27:1036-1040.
25. Harmer C.J., Mackay C.E., Reid C.B., Cowen P.J., Goodwin G.M. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol. Psychiatry 2006, 59:816-820.
26. Hirschfeld R.M. Antidepressants in long-term therapy: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr. Scand. Suppl. 2000, 403:35-38.
27. Katz M.M., Tekell J.L., Bowden C.L., Brannan S., Houston J.P., Berman N., Frazer A. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 2004, 29:566-579.
28. Kober H., Barrett L.F., Joseph J., Bliss-Moreau E., Lindquist K., Wager T.D. Functional grouping and cortical-subcortical interactions in emotion: a meta-analysis of neuroimaging studies. Neuroimage 2008, 42:998-1031.
29. Lopez-Sola M., Pujol J., Hernandez-Ribas R., Harrison B.J., Contreras-Rodriguez O., Soriano-Mas C., Deus J., Ortiz H., Menchon J.M., Vallejo J., Cardoner N. Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder. Neuropsychopharmacology 2010, 35:2305-2317.
30. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003, 19:1233-1239.
31. Mathews A., MacLeod C. Cognitive vulnerability to emotional disorders. Annu. Rev. Clin. Psychol. 2005, 1:167-195.
32. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 1999, 156:675-682.
33. Norbury R., Mackay C.E., Cowen P.J., Goodwin G.M., Harmer C.J. Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br. J. Psychiatry 2007, 190:531-532.
34. Nutt D.J. The neuropharmacology of serotonin and noradrenaline in depression. Int. Clin. Psychopharmacol. 2002, 17(Suppl. 1):S1-S12.
35. Paulus M.P., Feinstein J.S., Castillo G., Simmons A.N., Stein M.B. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch. Gen. Psychiatry 2005, 62:282-288.
36. Paulus M.P., Stein M.B. An insular view of anxiety. Biol. Psychiatry 2006, 60:383-387.
37. Phan K.L., Wager T., Taylor S.F., Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 2002, 16:331-348.
38. Phelps E.A., LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005, 48:175-187.
39. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol. Psychiatry 2003, 54:504-514.
40. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol. Psychiatry 2003, 54:515-528.
41. Sara S.J. The locus coeruleus and noradrenergic modulation of cognition. Nat. Rev. Neurosci. 2009, 10:211-223.
42. Schloss P., Henn F.A. New insights into the mechanisms of antidepressant therapy. Pharmacol. Ther. 2004, 102:47-60.
43. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33. quiz 34-57.
44. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., Mintun M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry 2001, 50:651-658.
45. Takahashi H., Yahata N., Koeda M., Takano A., Asai K., Suhara T., Okubo Y. Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study. Neuroimage 2005, 27:991-1001.
46. Turcotte J.E., Debonnel G., de Montigny C., Hebert C., Blier P. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. Neuropsychopharmacology 2001, 24:511-521.
47. van der Ploeg H.M. Zelf-Beoordelings Vragenlijst. Handleiding: Addendum 1981 1981, Swets & Zeitlinger, Lisse.
48. van der Ploeg H.M., Defares P.B., Spielberger C.D. Handleiding bij de Zelf-Beoordelings Vragenlijst, ZBV: Een Nederlandse vertaling van de Spielberger State-Trait Anxiety Inventory 1980, Swets & Zeitlinger, Lisse.
49. van Wingen G.A., van Broekhoven F., Verkes R.J., Petersson K.M., Backstrom T., Buitelaar J.K., Fernandez G. Progesterone selectively increases amygdala reactivity in women. Mol. Psychiatry 2008, 13:325-333.
50. Windischberger C., Lanzenberger R., Holik A., Spindelegger C., Stein P., Moser U., Gerstl F., Fink M., Moser E., Kasper S. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. Neuroimage 2010, 49:1161-1170.